Spero Therapeutics (SPRO) Q2 2026 Earnings Call Transcript
CEO Rajavelu discusses $105 million financing and SP001 immunology strategy.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Spero Therapeutics (SPRO) Q2 2026 Earnings Call Transcript finance.yahoo.com